The analysis, published in the American Journal of Ophthalmology, evaluated results of a multicenter phase 1 and 2 clinical trial that tested C-KAD, an eye-drop solution developed by Livionex, ...

While there are currently no FDA-approved pharmacological therapies for the treatment of cataracts, an eye drop demonstrated promising vision improvements in patients with early-stage cataracts in ...

Cataract surgery to restore vision as we age is the world’s most common procedure, but a new analysis of research conducted at the John A. Moran Eye Center supports further testing to determine if ...